STAT+: Pharmalittle: Novavax faces raw-materials shortages for Covid-19 shot; India curbs vaccine exports
And so, another working week will soon draw to a close. Not a moment too…
Category: Pharma
STAT+: With time running out, an ALS patient fights with Biogen over expanded access to its drug
Earlier this year, Lisa Stockman Mauriello was diagnosed with a fast-moving form of ALS, a…
STAT+: EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance
Amid rising concern over antibiotic resistance, a coalition of advocacy groups has filed a lawsuit…
HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access
Seeking to quickly widen global access to Covid-19 vaccines, academics, and patient advocates are urging…
STAT+: Pharmalittle: AstraZeneca revises Covid-19 vaccine effectiveness; contractors grab a big slice of vaccine revenues
Good morning, everyone, and how are you today? The sun is trying to peek through…
STAT+: Behind the scenes, companies helping big Covid-19 vaccine makers are getting rich
Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from…
Pushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine
Rejecting sharp criticism from U.S. government scientists, AstraZeneca said Wednesday night that its Covid-19 vaccine…
STAT+: Pfizer hopes for a happy ending for an osteoarthritis drug with a troubled history
For more than a decade, Pfizer has run dozens of trials in hopes of eventually…
Universities launch opioid litigation archive to ‘ensure history doesn’t repeat itself’
After two decades in which opioid overdoses claimed more than 400,000 lives in the U.S.,…
STAT+: Pharmalittle: Europe moves to curb Covid-19 vaccine exports; Slaoui fired from Galvani board over sexual harassment claim
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
.jpg)
Opinion: STAT+: A Biden-Harris Biomanufacturing Initiative could increase supplies of vaccines, therapeutics in one fell swoop
The coronavirus pandemic is generating pressure on the manufacturing of vaccines and therapeutics. Every day…
STAT+: After leading a corporate turnaround, a swashbuckling CEO flies AstraZeneca into turbulence
It took eight years, a failed hostile takeover, and a sweeping scientific turnaround for AstraZeneca…
STAT+: AbbVie accuses a company of recruiting an employee in order to steal Humira secrets
Two years ago, a manufacturing team leader at AbbVie (ABBV) took a similar job at…
STAT+: Pharmalittle: AstraZeneca may have used ‘outdated’ info about its Covid-19 shot; Democrats eye drug-pricing measures
Rise and shine, everyone, another busy day is on the way. We can tell by…
STAT+: Lawmakers introduce a bill to prevent Sacklers from using bankruptcy ‘loophole’ to evade liability
In a move directed at the owners of Purdue Pharma, a pair of Democratic lawmakers…
STAT+: Pharmalittle: AstraZeneca says studies show its Covid-19 vaccine is 79% effective; rich countries created vaccine inequity
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
José Baselga, renowned cancer researcher and AstraZeneca oncology R&D head, dies at 61
José Baselga, a storied oncology researcher and pharmaceutical executive whose discoveries helped pave the way…
.jpg)
‘The public is being denied the truth’: A legal expert blasts Purdue’s bankruptcy plan to end opioid lawsuits
Earlier this week, Purdue Pharma filed a bankruptcy plan that would have some members of…
STAT+: Pharmalittle: Some European countries to resume use of AstraZeneca Covid-19 shot; Senate confirms Becerra as HHS secretary
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Does a drug’s name affect how patients and doctors perceive it? The FDA wants to know
Drug makers may spend untold sums of money giving medicines zippy names. Now, regulators want…
STAT+: Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed
Amid increasing concern over antibiotic resistance, a new analysis found that nearly 56% of the…
STAT+: AmerisourceBergen say-on-pay proposal squeaks by amid outrage over CEO compensation
In a rebuke to AmerisourceBergen (ABC), nearly half of its shareholders voted against a “say-on-pay”…
STAT+: Pharmalittle: Europe isn’t ruling out waiving IP rights for Covid-19 shots; AstraZeneca defends vaccine production process
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: Pharma wins a round in a battle with HHS over a drug discount program for hospitals
In a victory for the pharmaceutical industry, a federal judge temporarily blocked the federal government…
STAT+: Pharmalittle: Pfizer looks to raise price of Covid-19 shot after pandemic ends; FTC will be tougher on pharma mergers
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Washington may become the second state to distribute its own generic drugs
A bill moving through the Washington legislature may make the state only the second in…
STAT+: Pharma mergers face fresh scrutiny by a new international antitrust group
In response to a spate of pharmaceutical mergers, several antitrust regulators and enforcement agencies from…
STAT+: Pharmalittle: More countries halt use of AstraZeneca Covid-19 vaccine; Moderna studies its shot in children
Rise and shine, another busy day is on the way. Most days are busy, though,…
Sacklers boost Purdue Pharma settlement to $4.3 billion in plan that would end their control of the opioid maker
In a move that could spell the end of Purdue Pharma, the company has filed…
STAT+: Once again, the viability of the U.S. biosimilar market is thrown into question
Despite periodic reports that biosimilars have finally arrived and will save the U.S. health care…
STAT+: Pharmalittle: Covid-19 vaccine shortages prompt new manufacturing alliances; WHO endorses AstraZeneca shot
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: U.S. sits on millions of AstraZeneca vaccine doses; WTO again fails to act on Covid-19 proposal
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Choosing the right director for the U.S. Patent and Trademark Office can help lower drug prices
As the Biden administration fills key Cabinet positions, its attention must turn to other critical…
Opinion: Reining in drug patents isn’t a silver bullet against high drug prices
One of the top orders of business for the Biden administration is curbing drug prices….
STAT+: Ohio attorney general sues a health plan over its PBM contracts and Medicaid costs
In the latest bid to pull back the curtain on pharmacy benefit managers, the Ohio…
STAT+: Medicare spending on neurology drugs jumped, while number of claims barely budged
During a recent five-year period, Medicare spending on hundreds of medicines to treat various neurologic…
STAT+: Pharmalittle: Lilly fired manager who tracked employee production complaints; Denmark suspends AstraZeneca shot
Top of the morning to you, and a fine one it is. We say this…
‘Deeply problematic’: AmerisourceBergen rewards its CEO despite the ravages of the opioid crisis
You can file this under, “What opioid crisis?” In one of the more startling examples…
STAT+: Antibiotic prescribing during the pandemic raises concern about drug resistance
Amid rising worries over antibiotic resistance, a new study suggests the drugs were overprescribed to…
STAT+: Pharmalittle: Biden urged by former FDA commissioners to pick agency chief; Lilly reports more positive data for Covid-19 drug
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal
Rise and shine, another busy day is on the way. We can tell it is…
STAT+: Drug makers urge Biden to reject proposal to waive patent rights on Covid-19 products
More than two dozen of the largest pharmaceutical companies are urging President Biden to reject…
STAT+: FDA reviews accelerated approvals as two drug makers withdraw bladder cancer indications
For the second time in less than a month, a drug maker has pulled an…
STAT+: Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: STAT+: Making pharma’s post-Covid-19 future faster and smarter
There’s nothing like a global pandemic to force a reimagining of one’s business. What it…
STAT+: Lawmakers rail against huge tax breaks drug wholesalers get from opioid settlement
Three congressional lawmakers are examining the extent to which pharmaceutical wholesalers and a leading drug…
STAT+: European Commission probes Teva for allegedly using patents to thwart competition
In its latest bid to ensure competition among drug makers, the European Commission has opened…
STAT+: Pharmalittle: Serum CEO warns of shortage of vaccine components; EU to extend Covid-19 export scheme
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Physician and patients may prefer brand-name drugs, but they cost Medicare Part D a lot of money
Generic drugs may remain lower-cost alternatives to brand-name medicines, but the Medicare Part D program…
STAT+: Pharmalittle: Novartis to help make CureVac Covid-19 vaccine; U.K. to speed vaccine approvals for Covid-19 variants
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…